The life sciences industry enters 2026 with cautious confidence. After two years of volatility, the sector has found its footing in an environment that rewards disciplined growth, sharper portfolio decisions and capital efficiency.
This report from In Vivo brings together data, insights and perspectives that provide clarity for innovators, dealmakers, pharma strategists and investors.
Choose a time to talk
専門家との相談日時を選択
Calendar requires cookies. Enable cookies
カレンダーの表示にはCookieの有効化が必要です Cookieを有効にする
Or send us a message and we'll be in touch
面談の有無がお決まりでない場合は、お問い合わせ内容をお送りください。担当者よりご連絡いたします。